Dolby Laboratories (Dolby Laboratories) Risk Assessment

View and export this data going back to 2005. Start your Free Trial

What is Dolby Laboratories Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Dolby Laboratories is: Low Risk: Strong fundamentals, worth long-term holding.

Competitive Comparison of Dolby Laboratories's Risk Assessment

For the Specialty Business Services subindustry, Dolby Laboratories's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dolby Laboratories's Risk Assessment Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Dolby Laboratories's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Dolby Laboratories's Risk Assessment falls into.

Dolby Laboratories (NYSE:DLB) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Dolby Laboratories Risk Assessment Related Terms

Thank you for viewing the detailed overview of Dolby Laboratories's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Dolby Laboratories (Dolby Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Dolby Laboratories Inc (NYSE:DLB) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

FUO:Germany FUO:Germany

Address

1275 Market Street, San Francisco, CA, USA, 94103-1410

Website

https://www.dolby.com

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Executives

Kevin J Yeaman	officer: VP, Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Mark Andrew Sherman	officer: EVP, GEN. COUN. & SECRTY	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
John D Couling	officer: SVP, Entertainment	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Todd Pendleton	officer: SVP, Chief Marketing Officer	1275 MARKET STREET, SAN FRANCISCO CA 94103
Emily Rollins	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Anjali Sud	director	C/O VIMEO INC., 555 WEST 18TH STREET, NEW YORK NY 10011
Simon Segars	director	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Avadis Tevanian	director	DOLBY LABORATORIES INC, 1275 MARKET STREET, SAN FRANCISCO CA 94103
Peter C Gotcher	director
Ryan Nicholson	officer: VP, Corporate Controller	C/O DOLBY LABORATORIES INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Shriram Revankar	officer: SVP, Advanced Technology Group	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Tony A Prophet	director	9 BERNICE STREET, SAN FRANCISCO CA 94103
Robert J Park	officer: SVP & Chief Financial Officer	C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103
Steven E Forshay	officer: Sr. Vice President, Research	1275 MARKET STREET, SAN FRANCISCO CA 94103
Lewis Chew	officer: EVP, Chief Financial Officer	DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO CA 94103